Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: A randomized, double-blind comparative study

Journal of Tropical Pediatrics

Volumn 53, Issue 5, 2007, Pages 303-307

  Sapru, Amita ^a   Kulkarni, P S ^b   Bhave, Sheila ^a   Bavdekar, Ashish ^a   Naik, S S ^a   Pandit, Anand N ^a  

^a KEM HOSPITAL   (India)

^b Serum Institute of India Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENEVAC B; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BRONCHIOLITIS; CLINICAL TRIAL; COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG FEVER; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULITIS; GASTROENTERITIS; GEOMETRY; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INDIAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SEROCONVERSION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SWELLING; URINARY TRACT INFECTION; VACCINATION; VOMITING;

AGE FACTORS; DOUBLE-BLIND METHOD; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INDIA; INFANT, NEWBORN; MALE; SAFETY; VACCINES, SYNTHETIC;

EID: 36249001715     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmm016     Document Type: Article

References (20)

1. Goldstein ST, Zhou F, Hadler SC, et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-39.
2. Szmuness W, Stevens CE, Harley EL et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833-41.
3. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
4. Aggarwal R, Ghoshal UC, Naik SR. Assessment of cost effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol 2003;38:215-22.
5. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79: 255-63.
6. Vijayakumar V, Hari R, Parthiban R, et al. Evaluation of immunogenicity and safety of Genevac B: A new recombinant hepatitis b vaccine in comparison with Engerix B and Shanvac B in healthy adults. Ind J Med Microbiol 2004;22:34-8.
7. Kulkarni PS, Raut SK, Phadke MA, et al. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults. Vaccine 2006;24:3457-60.
8. Vijayakumar V, Shraddha M, Subhadra N, et al. Immunogenicity and safety of 10mg and 20mg doses of Genevac-B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J Gastroenterol 2004;23:34-5.
9. Kakrani AL, Bharadwaj R, Karmarkar A, et al. Immune responses induced by two dose strengths of an yeast-derived recombinant hepatitis B vaccine in adolescents. Indian J Gastroenterol 2003;22:71-2.
10. Shivananda, Virbhadra Somani, Srikanth BS, et al. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India. Clin Vaccine Immunol 2006;13:661-4.
11. Hsu HM, Lu CF, Lee SC, et al. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: The effect of hepatitis B mass immunization. J Infect Dis 1999;179:367-70.
12. Yusuf HR, Daniels D, Smith P, et al. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 2000;284:978-83.
13. Belloni C, Chirico G, Pistorio A, et al. Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr 1998;87:336-8.
14. Bhave S, Bhise S, Chavan SC, et al. Hepatitis B vaccination in premature and low birth weight (LBW) babies. Indian Pediatr 2002;39:625-31.
15. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
16. Lolekha S, Warachit B, Hirunyachote A, et al. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002;20:3739-43.
17. Milne A, West DJ, Chinh DV, et al. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 2002;67:327-33.
18. Mittal SK, Rao S, Kumari S, et al. Simultaneous administration of hepatitis B vaccine with other E.P.I. vaccines. Indian J Pediatr 1994;61:183-8.
19. Panda SK, Ramesh R, Rao KV, et al. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants. J Med Virol 1991;35:297-302.
20. MIMS India Monthly Index of Medical Specialities. 2006; 26: 228-9.